MétaCan
Menu
Back to cohort
Record W4401688491 · doi:10.1200/jco-24-01373

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

2024· article· en· W4401688491 on OpenAlexaff
Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Vittorio Ruggero Zilioli, Elsa Pennese, Luca Arcaini, Anna Dąbrowska‐Iwanicka, Andrés J.M. Ferreri, Francesco Merli, Weili Zhao, Luigi Rigacci, Claudia Cellini, David Hodgson, C Ionescu, Carla Minoia, Elisa Lucchini, Michele Spina, Alexander Fosså, Andrea Janíková, Kate Cwynarski, N. George Mikhaeel, Mats Jerkeman, Alice Di Rocco, Yana Stepanishyna, Umberto Vitolo, Armando Santoro, Alessandro Re, Benedetta Puccini, Jacopo Olivieri, Luigi Petrucci, Sally F. Barrington, Bogdan Małkowski, Ur Metser, Annibale Versari, Stéphane Chauvie, Jan Walewski, Marek Trněný, F. Cavalli, Mary Gospodarowicz, Peter Johnson, Andrew Davies, Emanuele Zucca, John Kuruvilla, Li Wang, David Balada, Andreas Huettmann, F. Angrilli, Ombretta Annibali, Oreste Bagni, Roberta Battistini, Maria Giuseppina Cabras, Teresa Calimeri, Califano Catello, Federica Cavallo, Patrizia Ciammella, Ugo Consoli, Vitaliana De Sanctis, Nicola Di Renzo, Alberto Fabbri, Angela Ferrari, Andrés J.M. Ferreri, Leonardo Flenghi, Gianluca Gaïdano, Guido Gini, Manuel Gotti, Attilio Guarini, Anna Marina Liberati, Donato Mannina, Fabio Matrone, Francesco Merli, Carla Minoia, Anna Lia Molinari, Gerardo Musuraca, Luca Nassi, Francesco Passamonti, Domenico Pastore, Caterina Patti, Sabrina Pelliccia, Francesco Piazza, Francesco Pisani, Michele Pizzuti, Samantha Pozzi, Emanuele Ravano, Francesca Re, Marianna Sassone, Vittorio Stefoni, Caterina Stelitano, Giuseppe Tarantini, Corrado Tarella, Daniele Vallisa, Francesco Zaja, Manuela Zanni, Unn‐Merete Fagerli, Marco A. DaSilva, Ngwa Che Azinwi, Franco Cavalli, Letizia Deantonio, Felicitas Hitz, Walter Mingrone, Alden A. Moccia, Urban Novak, Maria Cristina Pirosa, Anastasios Stathis, Kelly Cozens, Christopher P. Fox, Tim Illidge, Rod Johnson, Pam McKay, Alison Milne, Shah Nimish, Wendy Osborne, Shankara Paneesha, Andrew R. Pettitt, Don A. Stevens, Luca Ceriani Stephane Chauvie Bogdan Malkowski, L. Bonomini, Nicoletta Ielmini

Bibliographic record

VenueJournal of Clinical Oncology · 2024
Typearticle
Languageen
FieldMedicine
TopicLymphoma Diagnosis and Treatment
Canadian institutionsUniversity of TorontoUniversity Health NetworkPrincess Margaret Cancer Centre
FundersNational Institute for Health and Care Research
KeywordsMedicineRadiation therapyLymphomaRadiologyOncologyInternal medicine

Abstract

fetched live from OpenAlex

PURPOSE: The role of consolidation radiotherapy in patients with primary mediastinal B-cell lymphoma (PMBCL) is controversial. METHODS: The IELSG37 trial, a randomized noninferiority study, aimed to assess whether irradiation can be omitted in patients with PMBCL with complete metabolic response (CMR) after induction immunochemotherapy. The primary end point was progression-free survival (PFS) at 30 months after random assignment. Patients with CMR were randomly assigned to observation or consolidation radiotherapy (30 Gy). With a noninferiority margin of 10% (assuming a 30-month PFS of 85% in both arms), a sample size of 540 patients was planned with 376 expected to be randomly assigned. RESULTS: The observed events were considerably lower than expected; therefore, primary end point analysis was conducted when ≥95% of patients were followed for ≥30 months. Of the 545 patients enrolled, 268 were in CMR after induction and were randomly assigned to observation (n = 132) or radiotherapy (n = 136). The 30-month PFS was 96.2% in the observation arm and 98.5% in the radiotherapy arm, with a stratified hazard ratio of 1.47 (95% CI, 0.34 to 6.28) and absolute risk difference of 0.68% (95% CI, -0.97 to 7.46). The 5-year overall survival (OS) was 99% in both arms. Nonrandomized patients were managed according to local policies. Radiotherapy was the only treatment in 86% of those with Deauville score (DS) 4 and in 57% of those with DS 5. The 5-year PFS and OS of patients with DS 4 (95.8% and 97.5%, respectively) were not significantly different from those of randomly assigned patients. Patients with DS5 had significantly poorer 5-year PFS and OS (60.3% and 74.6%, respectively). CONCLUSION: This study, the largest randomized trial of radiotherapy in PMBCL, demonstrated favorable outcomes in patients achieving CMR with no survival impairment for those omitting irradiation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.102
GPT teacher head0.461
Teacher spread0.359 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations28
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicLymphoma Diagnosis and TreatmentFrench-language works237,207